A remarkable feature of regenerative processes is their ability to halt proliferation once an organ's structure has been restored. The Wnt signalling pathway is the major driving force for homeostatic self-renewal and regeneration in the mammalian intestine. However, the mechanisms that counterbalance Wnt-driven proliferation are poorly understood. Here we demonstrate in mice and humans that yes-associated protein 1 (YAP; also known as YAP1)-a protein known for its powerful growth-inducing and oncogenic properties 1,2 -has an unexpected growth-suppressive function, restricting Wnt signals during intestinal regeneration. Transgenic expression of YAP reduces Wnt target gene expression and results in the rapid loss of intestinal crypts. In addition, loss of YAP results in Wnt hypersensitivity during regeneration, leading to hyperplasia, expansion of intestinal stem cells and niche cells, and formation of ectopic crypts and microadenomas. We find that cytoplasmic YAP restricts elevated Wnt signalling independently of the AXIN-APC-GSK-3b complex partly by limiting the activity of dishevelled (DVL). DVL signals in the nucleus of intestinal stem cells, and its forced expression leads to enhanced Wnt signalling in crypts. YAP dampens Wnt signals by restricting DVL nuclear translocation during regenerative growth. Finally, we provide evidence that YAP is silenced in a subset of highly aggressive and undifferentiated human colorectal carcinomas, and that its expression can restrict the growth of colorectal carcinoma xenografts. Collectively, our work describes a novel mechanistic paradigm for how proliferative signals are counterbalanced in regenerating tissues. Additionally, our findings have important implications for the targeting of YAP in human malignancies.
A remarkable feature of regenerative processes is their ability to halt proliferation once an organ's structure has been restored. The Wnt signalling pathway is the major driving force for homeostatic self-renewal and regeneration in the mammalian intestine. However, the mechanisms that counterbalance Wnt-driven proliferation are poorly understood. Here we demonstrate in mice and humans that yes-associated protein 1 (YAP; also known as YAP1)-a protein known for its powerful growth-inducing and oncogenic properties 1,2 -has an unexpected growth-suppressive function, restricting Wnt signals during intestinal regeneration. Transgenic expression of YAP reduces Wnt target gene expression and results in the rapid loss of intestinal crypts. In addition, loss of YAP results in Wnt hypersensitivity during regeneration, leading to hyperplasia, expansion of intestinal stem cells and niche cells, and formation of ectopic crypts and microadenomas. We find that cytoplasmic YAP restricts elevated Wnt signalling independently of the AXIN-APC-GSK-3b complex partly by limiting the activity of dishevelled (DVL). DVL signals in the nucleus of intestinal stem cells, and its forced expression leads to enhanced Wnt signalling in crypts. YAP dampens Wnt signals by restricting DVL nuclear translocation during regenerative growth. Finally, we provide evidence that YAP is silenced in a subset of highly aggressive and undifferentiated human colorectal carcinomas, and that its expression can restrict the growth of colorectal carcinoma xenografts. Collectively, our work describes a novel mechanistic paradigm for how proliferative signals are counterbalanced in regenerating tissues. Additionally, our findings have important implications for the targeting of YAP in human malignancies.
YAP is a critical component of the Hippo signalling pathway, which controls organ size in mammals 1, 2 . Through a kinase cascade, the pathway targets YAP for phosphorylation, preventing its translocation to the nucleus, where it functions as a transcriptional co-activator. Current dogma suggests that restriction of the transcriptional activity of YAP is the principal mechanism of growth and tumour suppression by the Hippo pathway 2 . Indeed, nuclear YAP is a powerful driver of organ growth, progenitor proliferation and tumour growth [1] [2] [3] [4] . We previously assessed YAP function in the mammalian intestine by using a mouse model that resulted in ubiquitous postnatal expression of an inducible YAP(S127A) mutant 3 . This mutant protein is thought to have enhanced nuclear localization given that it escapes inactivation by the Hippo kinases LATS1 and LATS2 (ref. 3) . As YAP might activate paracrine signals 5 , we sought to bypass non-cell-autonomous effects by specifically expressing YAP in the intestinal epithelium using the Villin-rtTA driver 6 . YAP protein in the intestine of transgenic mice was not restricted to the nucleus, suggesting that S127 is not the major determinant of YAP subcellular localization in this tissue (Supplementary Fig. 1a ). Five-to-seven days after doxycycline (Dox) administration, transgenic mice became moribund and were killed. Surprisingly, histological evaluation of the small intestine and colon of transgenic mice revealed a progressive degenerative phenotype associated with the rapid loss of proliferating crypts ( Fig. 1a and Supplementary Fig. 1b, c) .
Crypt-loss phenotypes are typically associated with reduced Wnt signalling 7 . Indeed, degeneration was accompanied by repression of the Wnt target gene Cd44 and loss of cells with nuclear b-catenin ( Fig. 1b and Supplementary Fig. 1e -g). Paneth cells are a mature intestinal lineage that require high levels of Wnt signalling for their proper differentiation and localization, and function as a critical component of the intestinal stem cell (ISC) niche 8,9 . mice, Paneth cells become mislocalized and eventually disappear ( Supplementary Fig. 1d ). To determine if YAP expression was reducing ISC numbers, we performed in situ hybridization (ISH) for Olfm4, which marks crypt base columnar (CBCs) stem cells 10 . Olfm4 1 CBCs were markedly reduced 2 days after induction and were essentially absent by day 4 (Fig. 1c ). Consistent with these data, microarray analysis on isolated crypts showed that many robustly downregulated transcripts were known ISC signature genes (that is, Olfm4, Ascl2, Smoc2 and Lgr5) ( Fig. 1d and Supplementary Fig. 2a, b ). Gene set enrichment analysis (GSEA) demonstrated significant downregulation of both intestinal b-catenin targets and a recently described ISC gene signature 11, 12 ( Supplementary Fig. 1c and Supplementary Table 1 ). Inhibition of growth, loss of Paneth cells and suppression of Wnt/ISC signature genes were confirmed in organoid cultures derived from transgenic mice ( Supplementary Fig. 2d , e) 9 . Together, these results demonstrate that, in contrast to other tissues where it promotes growth, epithelial-specific expression of YAP suppresses intestinal renewal, which occurs through inhibition of the Wnt signalling pathway.
These observations prompted us to evaluate more carefully the phenotype of gut-specific YAP mutant mice. Consistent with a previous report 13 , developmental or acute YAP loss produced no major abnormalities during normal intestinal homeostasis ( Fig. 2b and Supplementary Fig. 3a ). However, after injury by whole-body irradiation (9 and 11 Gy), Villin-Cre Yap fl/fl (conditional knockout (cKO)) mice showed a phenotype of crypt hyperplasia and overgrowth throughout the small intestine and colon ( Fig. 2a and Supplementary Fig. 3c, e ). This observation contrasts to that of the impaired repair observed in a dextran sulphate sodium salt (DSS)-mediated colitis model 13 ( Supplementary  Fig. 3b ). cKO crypts were hyperproliferative and showed upregulation of the Wnt target genes Cd44 and Sox9 as well as mislocalized and increased numbers of Paneth cells ( Fig. 2a and Supplementary Fig. 3f ). Apoptosis was not altered in cKO mice ( Supplementary Fig. 3d ). 
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Considering that intestinal regeneration after irradiation is characterized by a state of Wnt hyperactivity 14, 15 , our data suggest a role for YAP in restricting elevated Wnt signalling in vivo.
To test directly if loss of YAP results in Wnt hypersensitivity, we injected adenovirus expressing R-spondin1 (Ad-Rspo1; R-spondin1 also known as Rspo1) into cKO and control mice. Rspo1 is a potent secreted Wnt agonist that induces crypt-cell proliferation 16, 17 . Seven days after Ad-Rspo1 injection, 80% of cKO mice (n 5 8) became moribund and were killed, whereas Ad-Fc-injected control mice (n 5 8) appeared normal. The intestines and colon of cKO mice showed a massively hyperplastic phenotype, so that by day 7 most mature intestinal lineages in cKO epithelia were replaced by highly proliferative crypt-like tissue (Fig. 2b, c and Supplementary Fig. 4a-i) . Hyperplasia was accompanied by upregulation of Wnt targets CD44, SOX9 and EPHB3, in addition to global upregulation of the intestinal b-catenin target signature (Fig. 2d-f and Supplementary Fig. 4j ). To determine if YAP loss resulted in expansion of cells with the features of ISCs, we generated cKO:Lgr5-EGFP mice.
LGR5 is normally expressed in the CBCs at the very bottom of the crypt (Fig. 2g, inset) ; however, after Rspo1 administration in control mice, the population of Lgr5 1 ISCs expands (Fig. 2g ). This expansion is much more marked in the cKO intestine, where the Lgr5 1 domain is 3-4 times larger. ISC expansion was confirmed by ISH for Olfm4 ( Supplementary Fig. 5a ), and by GSEA ( Fig. 2e and Supplementary Table 1 ). cKO mice also showed a prominent increase in Paneth cell numbers ( Fig. 2h and Supplementary Fig. 5b, c, d) . Paneth cells and LGR5 1 cells were evident high in the crypt/villus axis ( Fig. 2g and Supplementary Fig. 5c, d) . We also observed ectopic epithelial foci resembling crypts in cKO mice, which had formed within villi and stained positive for CD44, lysozyme and proliferative markers ( Fig. 2i and Supplementary Fig. 5e-g) . Some of these progressed into structures reminiscent of microadenomas, which are pre-cancerous lesions of outpocketing pouches of crypt-like tissue that grow into normal villi ( Supplementary Fig. 5g ). These were never observed in control Rspo1-treated animals. Together, these results demonstrate that YAP restricts the expansion of ISCs as well as critical components of the stem cell niche.
To gain insight into the mechanism behind our observations, we revisited the expression pattern of YAP in the intestine. It has previously been shown that YAP is primarily localized to the crypt base, and is absent from villi 3, 13 . Using a new polyclonal antibody, we find that YAP is enriched in the nucleus of CBCs and lower crypt cells ( Supplementary Fig. 6a -c) but was also expressed in upper transit amplifying (TA) cells and throughout the villi, where it is predominantly cytoplasmic ( Supplementary Fig. 6a ). This was confirmed by cellular fractionation experiments ( Supplementary Fig. 6d ). YAP localization correlated with the staining pattern of CD44, demonstrating that nuclear YAP is present in zones of active Wnt signalling, but is mostly cytoplasmic where Wnt is restricted ( Supplementary  Fig. 6e ). These data indicate that cytoplasmic YAP might be functionally responsible for terminating Wnt signalling and allowing progress from a proliferative progenitor/stem cell compartment to a post-mitotic, differentiated fate. To rule out the possibility that a transcriptional function of YAP was repressing Wnt, we generated Yap fl/S79A Villin-Cre mice. The YAP protein in these mutants cannot bind to TEAD transcription factors, the main transcriptional effectors of YAP 18, 19 . After Rspo1 injection, we observed no enhanced Wnt response in YAP(S79A) mutant mice ( Supplementary Fig. 7a ). Supporting a role for cytoplasmic YAP in restricting Wnt signalling, expression of YAP wild-type and a YAP(S127D) phospho-mimic limited Wnt reporter responsiveness in 293T cells ( Supplementary Fig. 7b, c) .
The phenotype observed in cKO mice treated with Rspo1 histologically resembled acute Apc deletion ( Supplementary Fig. 8 ) 20 . Surprisingly, we observed no obvious changes in b-catenin protein levels in hyperplastic cKO crypts ( Supplementary Fig. 8a-c) . As increases in b-catenin protein are the direct consequence of disrupting the AXIN-APC-GSK-3b complex, these data suggest that YAP restriction of Wnt signalling is probably not mediated by modulating the activity of this complex. It has been recently suggested that phosphorylated cytoplasmic YAP sequesters b-catenin in the cytoplasm in cell lines 21 . Although we observed a subtle expansion in the number of nuclear b-catenin-positive cells in cKO mucosa ( Supplementary  Fig. 8b ), these probably represent the expansion of Paneth cells and we infer that this does not represent the major mechanism of YAPmediated Wnt repression. In vitro, we observed increased Wnt activity after combined YAP and APC depletion versus knockdown of APC only, and a synergistic effect of YAP depletion together with GSK-3b small-molecule inhibition ( Supplementary Fig. 8d, e ). In mice, combined deletion of APC and YAP (double knockout) versus APC only in an acute or a long-term adenoma model 22 resulted in a robust upregulation of CD44 in addition to significant increases in the number of Paneth cells and proliferative cells ( Supplementary Fig. 9a-g) . Thus, our data suggest that YAP acts to restrict Wnt signalling independently to, and in some cases synergistically with, the activity of the destruction complex and control of subcellular localization of b-catenin.
Recently, it was reported that TAZ, a protein that bears a 57% homology to YAP, interacts with DVL 23 , a positive Wnt signalling regulator. Work primarily done in Drosophila has shown that DVL acts in the cytoplasm upstream of the b-catenin destruction complex. However, emerging work in mammals suggests that DVL also exists in the nucleus, mediating the Wnt transcriptional response partly in conjunction with c-Jun and TCF4 (refs 24, 25) . We determined that YAP also interacts with DVL2 ( Supplementary Fig. 10a ). The function of DVLs in intestinal regeneration has been poorly characterized, although the observation that loss of DVL2 causes a decrease in intestine length and crypt diameter suggests an important role in 310 (a, b) , 320 (c) and 34 (e).
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intestinal biology 26 . We find that DVL2 expression is restricted to the crypt compartment, where it is localized in the nucleus of CBCs and assumes a more diffuse pattern in the TA compartment (Fig. 3a) . Furthermore, DVL2 nuclear localization is enhanced in crypts after Rspo1 administration and during regeneration following irradiation ( Fig. 3b and Supplementary Fig. 10b ). To evaluate the role of nuclear DVL in crypts, we infected intestinal organoids with lentiviruses expressing a Dox-inducible DVL carrying a nuclear localization signal (DVL-NLS) 25 . DVL-NLS increases Wnt target gene expression and leads to the transient formation of spheroid organoids resembling those with constitutive Wnt signalling (Fig. 3e) 9 . In addition, expression of DVL-NLS after APC knockdown results in a synergistic activation of the TOPflash Wnt reporter ( Supplementary Fig. 10c ). Thus, our findings are consistent with an important nuclear function of DVL in intestinal progenitors and Wnt signalling in parallel to or downstream of the destruction complex. Given the observed physical interaction between YAP and DVL2 and their overlapping patterns of subcellular localization in crypts, we proposed that YAP might control DVL2 subcellular localization and/or activity. We observed a massive expansion of cells positive for nuclear DVL2 in cKO mice treated with Rspo1 and during radiation-induced regeneration ( Fig. 3b and Supplementary Fig. 10b ). Additionally, YAP knockdown led to DVL nuclear accumulation in DLD1 cells ( Fig. 3c and Supplementary Fig. 10d, e ). We found no increase in levels of nuclear b-catenin in this context ( Supplementary Fig. 10e ). Loss of DVL2 and DVL3 partially or completely rescued increased Wnt target gene expression in the absence of YAP (Fig. 3d ). To determine if YAP could block DVL-induced Wnt transcriptional responses, we generated organoids expressing Dox-inducible DVL-NLS ( Supplementary Fig. 10f ) and YAP. Expression of YAP completely abrogated the DVL-mediated upregulation of the Wnt target genes Lgr5 and Axin2 (Fig. 3e) . Therefore, we conclude that YAP is critical for the proper subcellular localization of DVLs and blocks their ability to induce Wnt signalling.
Finally, we investigated the role of YAP in human colorectal carcinoma. Using DLD1 cells infected with Dox-inducible YAP wild type or YAP(S127D), we performed xenograft assays to assess the effect of YAP on tumour growth. We found a marked decrease in tumour growth with the addition of Dox, particularly with YAP(S127D) ( Fig. 4a and Supplementary Fig. 11a, b ). This decrease in tumour size coincided with global suppression of the colorectal carcinoma TCF4/b-catenin 27 and ISC 11 gene signatures (Fig. 4b, c , Supplementary Fig. 11c, d and Supplementary Table 1 ). We next examined if YAP loss was associated with human colorectal carcinoma by evaluating YAP expression in a cohort of 672 colorectal carcinoma samples using immunohistochemistry 28 . Complete loss of YAP staining occurred within a minor subset of human tumours (10.5%), but predicted worse patient survival and was associated with high-grade, stage IV disease, compared with YAP-positive groups ( Supplementary  Fig. 11e-h and Fig. 4d-f ). These results are consistent with our animal data and demonstrate that YAP may act as a tumour suppressor in human colorectal carcinoma.
Precise mechanisms must exist to dampen proliferative potential to maintain organ size. We have identified YAP and DVLs as key players in this process by restricting the expansion of ISCs and their niche during Wnt-driven regeneration. Although we have not ruled out a pro-proliferative role for nuclear YAP, our results suggest that the predominant function of YAP in the intestine is growth restrictive. During normal development and homeostasis, TAZ (whose expression is highly enriched in crypts; Supplementary Fig. 6d ) might be compensating for the loss of YAP. Alternatively, YAP together with DVL might be part of a regeneration-exclusive molecular machinery that helps counteract hyperactive Wnt signalling, which occurs during emergency growth. Interestingly, YAP is a WNT target gene 29 , suggesting that it might participate in a negative feedback loop to limit WNTinitiated signals. At present, therapeutic efforts are aimed at diminishing YAP protein levels in many malignancies, including colorectal carcinoma 30 . Our results suggest that such manipulations could potentially result in increased tumour growth. YAP-targeting therapies should aim to disrupt the YAP-TEAD interaction or to induce the cytoplasmic translocation of YAP. Further study of the role of YAP as a growth suppressor is likely to provide important insights into the biology of regeneration, size control and tumour progression. formation of DLD1 cells infected with lentivirus encoding Dox-inducible YAP wild type (WT) or YAP(S127D) mutant. Tumour photographs are representative images. Ruler is in centimetres. b, Heatmap representing the top 328 genes downregulated by YAP(S127D) induction in xenograft assays (n 5 3 tumours per treatment group). Labelled genes are known b-catenin targets in human colorectal carcinoma. c, GSEA of TCF4-dependent colorectal carcinoma (CRC) target genes. d, Overall survival analysis of patients with specific YAP staining patterns. YAP immunohistochemistry was placed into four groups of staining patterns correlating with subcellular localization from 672 colorectal cancer patients: cytoplasmic and nuclear (C (1) N (1)); cytoplasmic (C (1) N (2)); nuclear positive (C (2) N (1)); and complete loss of staining (C (2) N (2)). e, YAP staining in low-and high-grade tumours. Original magnification, 320. f, YAP loss is significantly associated with highgrade tumours and stage IV disease (CI, confidence interval; OR, odds ratio).
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